Biosenta Highlights Independent University of Calgary Research Validating Tri-Filler(TM) Antimicrobial Technology
Ontario and Calgary, Alberta--(Newsfile Corp. - July 21, 2026) - Biosenta Inc. (CSE: ZRO) ("Biosenta") today highlighted new research released by the University of Calgary demonstrating the performance of the Company's antimicrobial nanotechnology, Tri-Filler™, being developed in collaboration with researchers at the University of Calgary and the Alberta Centre for Advanced Diagnostics (ACAD). According to the University of Calgary, laboratory testing showed Tri-Fill
Biotechnology, Chemical, Household / Consumer / Cosmetics
2026-07-21 1:51 PM EDT | Biosenta Inc.
Bachem Plans to Build a Large-Scale Production Facility in Sisslerfeld
Bubendorf, Switzerland--(Newsfile Corp. - July 21, 2026) - Bachem (SIX: BANB) announced today the sig
Biotechnology, Chemical, Healthcare and Hospitals, Pharmaceuticals
2026-07-21 12:40 AM EDT | Bachem Holding AG
Telescope Announces Changes to its Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - July 14, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of intelligent automation and advanced chemical manufacturing technologies, announces that Ali Pejman has resigned from the Company's Board of Directors ("Board"), effective as of the date of this press release. Henry Dubina, CEO, stated, "On behalf of the Board and management, I would li
Technology, Chemical, Pharmaceuticals
2026-07-14 7:32 PM EDT | Telescope Innovations Corp.
Cerilon GTL ND Inc. Announces Definitive Agreement for Technology Licensing with Topsoe and Sasol for Their Gas-To-Liquids (GTL) Facility in Williams County, North Dakota
Calgary, Alberta--(Newsfile Corp. - June 23, 2026) - Cerilon GTL ND Inc. ("Cerilon") is pleased to announce that it has reached an agreement for a single point technology licensing structure with Topsoe and Sasol South Africa Ltd ("Sasol") for the hydrogen production, gas reforming, and Fischer Tropsch conversion components of Cerilon's Gas-To-Liquids ("GTL") facility in Williams County, North Dakota. The parties have completed negotiations on all definitive technology licensing agreements
Technology, Chemical, Energy, Alternative Energy
2026-06-23 10:00 AM EDT | Cerilon Inc.
Telescope Innovations to Attend Fastmarkets Global Lithium, Battery & Critical Materials in Las Vegas
Vancouver, British Columbia--(Newsfile Corp. - June 23, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of intelligent automation and advanced chemical manufacturing technologies, is pleased to announce that it will be attending the Fastmarkets Global Lithium, Battery & Critical Materials conference in Las Vegas, Nevada from June 23-2
Technology, Chemical, Pharmaceuticals
2026-06-23 8:00 AM EDT | Telescope Innovations Corp.
Sio Silica Welcomes International Partnerships Supporting Canada's Critical Minerals Resilience and Production Alliance
Winnipeg, Manitoba--(Newsfile Corp. - June 17, 2026) - Sio Silica Corporation ("Sio Silica" or the "Company") is pleased announce the advancement of strategic partnerships and collaborative initiatives designed to reinforce Canada's position as a global leader in critical minerals and advanced manufacturing strategy. By supporting innovative, value-added applications and domestic processing opportunities, these collaborations contribute to resilient supply chains, clean technology deve
Chemical, Mining and Metals, Non Ferrous Metal
2026-06-17 4:07 PM EDT | Sio Silica Corporation
Telescope Innovations Provides Financial Results of Third Fiscal Quarter 2026
Vancouver, British Columbia--(Newsfile Corp. - June 16, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE:J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended May 31, 2026 (Q3 FY2026). The Company generated revenues of approximately $2.1 million during this period, driven by a combination of contract services and Self-D
Technology, Chemical, Pharmaceuticals
2026-06-16 8:00 AM EDT | Telescope Innovations Corp.
Bachem Holding AG Announces Capital Markets Day 2026
Bubendorf, Switzerland--(Newsfile Corp. - June 12, 2026) - Bachem Holding AG (SIX: BANB) will host its Capital Markets Day on 26 November 2026 at The Circle Convention Center, Hyatt Regency Zurich Airport, as well as virtually. This hybrid event will provide insights into the company's strategic priorities, business outlook, and key developments.
Biotechnology, Chemical, Healthcare and Hospitals, Pharmaceuticals
2026-06-12 11:47 AM EDT | Bachem Holding AG
Telescope Innovations to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub
Vancouver, British Columbia--(Newsfile Corp. - June 11, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of intelligent automation and advanced chemical manufacturing technologies, is pleased to announce it will be presenting at the Planet MicroCap Las Vegas 2026 conference on Wednesday, June 17th, 2026. At Planet MicroCap, Dr. Jeffrey Sherman will provide an update on Telesc
Technology, Chemical, Pharmaceuticals
2026-06-11 8:00 AM EDT | Telescope Innovations Corp.
Telescope Innovations Founder and CTO, Professor Jason Hein, Receives 2026 SCI Canada LeSueur Memorial Award
Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") congratulates its Founder and Chief Technology Officer, Professor Jason Hein, on receiving the 2026 SCI Canada LeSueur Memorial Award from the Society of Chemical Industry ("SCI").
Technology, Chemical, Pharmaceuticals
2026-06-05 8:00 AM EDT | Telescope Innovations Corp.
Telescope Innovations Secures Third Self-Driving Lab Deployment with Major Global Pharmaceutical Company
Vancouver, British Columbia--(Newsfile Corp. - June 1, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of intelligent automation and advanced chemical manufacturing technologies, today announced that is has signed an agreement with a major global pharmaceutical company to deliver a Self-Driving Lab (SDL) platform at the company's European operations. The deployment, Telescope's third SDL pla
Technology, Chemical, Pharmaceuticals
2026-06-01 8:00 AM EDT | Telescope Innovations Corp.
TMC Group Commissions New Capacity to Support Next-Generation Radiotheranostics
Vancouver, British Columbia--(Newsfile Corp. - May 21, 2026) - As demand for radiotheranostics continues to grow exponentially, TMC Group, a Canadian manufacturer of high-purity enriched stable isotopes, is commissioning new production lines this year. This will add 50 percent more capacity to help ensure reliable supply for radiopharmaceutical research, clinical development, and future commercialization. TMC Group will be exhibiting at the 2026 Society of Nuclear Medicine and Molecular
Technology, Biotechnology, Chemical, Pharmaceuticals
2026-05-21 10:00 AM EDT | TMC Group
Telescope Innovations Shares Spring 2026 Conference and Events Lineup
Vancouver, British Columbia--(Newsfile Corp. - May 11, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries. The Company is pleased to report on outreach, marketing, and educational activities, both past and planned for spring 2026. Our participation includes presentations, exhibitions and keynote lect
Technology, Chemical, Pharmaceuticals
2026-05-11 8:00 AM EDT | Telescope Innovations Corp.
Bachem Announces Changes to the Corporate Executive Committee
Bubendorf, Switzerland--(Newsfile Corp. - May 5, 2026) - Bachem Holding AG (SIX: BANB) (“Bachem”) today announced that Torsten Wöhr, Chief Commercial Officer, has decided to pursue a new opportunity outside the company. Until a successor will be appointed, Anne-Kathrin Stoller will assume the role of Chief Commercial Officer in addition to her responsibilities as Chief Executive Officer (CEO), effective May 25, 2026. “Torsten Wöhr
Biotechnology, Chemical, Healthcare and Hospitals, Pharmaceuticals
2026-05-05 1:08 AM EDT | Bachem Holding AG
Bachem Annual General Meeting 2026
Bubendorf, Switzerland--(Newsfile Corp. - April 29, 2026) - Bachem Holding AG (SIX: BANB) (“Bachem”) announced today that its Annual General Meeting 2026 has approved all proposals of the Board of Directors. A total of 78,3% of the 74‘977‘940 eligible shares were present. The Annual General Meetin
Biotechnology, Chemical, Healthcare and Hospitals, Pharmaceuticals
2026-04-29 12:09 PM EDT | Bachem Holding AG
Bachem Secures Financing of Strategic Growth Initiatives
Bubendorf, Switzerland--(Newsfile Corp. - April 27, 2026) - Bachem Holding AG (SIX: BANB) (“Bachem”) announced today the closing of a revolving credit facility of C
Biotechnology, Chemical, Healthcare and Hospitals, Pharmaceuticals
2026-04-27 1:03 AM EDT | Bachem Holding AG
ColdBlock Technologies Inc. Announces Exclusive Distribution Partnership with Minas y Concentradoras S.A. in Peru
Niagara Falls, Ontario--(Newsfile Corp. - April 22, 2026) - ColdBlock Technologies Inc. (ColdBlock), developer of innovative sample digestion technology, is proud to announce a new partnership with Minas y Concentradoras S.A., a leading laboratory equipment distributor headquartered in Peru. This collaboration marks an important step in ColdBlock's continued expansion in Latin America, bringing its advanced sample digestion solutions to laboratories, researchers, and industry leaders ac
Technology, Agriculture, Chemical, Mining and Metals
2026-04-22 7:00 AM EDT | ColdBlock Technologies Inc
Telescope Innovations Provides Financial Results of Second Fiscal Quarter 2026
Vancouver, British Columbia--(Newsfile Corp. - April 13, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended February 28, 2026 (Q2 FY2026). The Company generated revenues of approximately $1.6 million during this period, with strong contributions from the development a
Technology, Chemical, Pharmaceuticals
2026-04-13 6:00 PM EDT | Telescope Innovations Corp.
Telescope Innovations Announces Expansion of Consulting Role for Dr. Joel M. Hawkins, Industry Leader in Process Chemistry Automation
Vancouver, British Columbia--(Newsfile Corp. - March 23, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries. The Company is pleased to announce that Dr. Joel M. Hawkins has expanded his consulting role with Telescope. Dr. Hawkins is an industry-wide authority in automating complex chemistry workflows
Technology, Chemical, Pharmaceuticals
2026-03-23 8:00 AM EDT | Telescope Innovations Corp.
Telescope Innovations and AGI SDA Launch Technology Development Collaboration
Vancouver, British Columbia--(Newsfile Corp. - March 16, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries, with established leadership in sampling systems for monitoring chemical and biological processes. The Company is pleased to announce that it has signed a Development and Collaboration Agreemen
Technology, Chemical, Pharmaceuticals
2026-03-16 8:00 AM EDT | Telescope Innovations Corp.